BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21094192)

  • 21. The degradation of the three layered nano-carbonated hydroxyapatite/collagen/PLGA composite membrane in vitro.
    Liao S; Watari F; Zhu Y; Uo M; Akasaka T; Wang W; Xu G; Cui F
    Dent Mater; 2007 Sep; 23(9):1120-8. PubMed ID: 17095082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
    Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
    Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell and platelet adhesions on plasma glow discharge-treated poly(lactide-co-glycolide).
    Khang G; Jeon JH; Lee JW; Cho SC; Lee HB
    Biomed Mater Eng; 1997; 7(6):357-68. PubMed ID: 9622103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the pore structure of poly(d,l-lactide-co-glycolide) microspheres.
    Vay K; Scheler S; Friess W
    Int J Pharm; 2010 Dec; 402(1-2):20-6. PubMed ID: 20883760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
    Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
    Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of fibroblast cells on poly(lactide-co-glycolide) surface with wettability chemogradient.
    Khang G; Lee SJ; Lee JH; Kim YS; Lee HB
    Biomed Mater Eng; 1999; 9(3):179-87. PubMed ID: 10572622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The miscibility of poly(D,L-lactide-co-glycolide) with amphiphilic molecules and the interaction of their mixtures with DNA at air/water interface.
    Sun L; Xu M; Wu L
    Colloids Surf B Biointerfaces; 2005 Jun; 43(1):29-35. PubMed ID: 15896947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of protein diffusion through poly(D,L-lactide-Co-glycolide).
    Fredenberg S; Reslow M; Axelsson A
    Pharm Dev Technol; 2005; 10(2):299-307. PubMed ID: 15926679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
    Duggirala SS; Mehta RC; DeLuca PP
    Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclic loading on in vitro degradation of poly(L-lactide-co-glycolide) scaffolds.
    Yang Y; Tang G; Zhao Y; Yuan X; Fan Y
    J Biomater Sci Polym Ed; 2010; 21(1):53-66. PubMed ID: 20040153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(lactide-co-glycolide) microspheres as a moldable scaffold for cartilage tissue engineering.
    Mercier NR; Costantino HR; Tracy MA; Bonassar LJ
    Biomaterials; 2005 May; 26(14):1945-52. PubMed ID: 15576168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(D,L-lactide-co-glycolide) dispersions containing pluronics: from particle preparation to temperature-triggered aggregation.
    Fraylich M; Wang W; Shakesheff K; Alexander C; Saunders B
    Langmuir; 2008 Aug; 24(15):7761-8. PubMed ID: 18570443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of divalent cations on pore formation and degradation of poly(D,L-lactide-co-glycolide).
    Fredenberg S; Reslow M; Axelsson A
    Pharm Dev Technol; 2007; 12(6):563-72. PubMed ID: 18161629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and morphology changes during in vitro degradation of electrospun poly(glycolide-co-lactide) nanofiber membrane.
    Zong X; Ran S; Kim KS; Fang D; Hsiao BS; Chu B
    Biomacromolecules; 2003; 4(2):416-23. PubMed ID: 12625740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of degradation behavior for PLGA in various pH condition by simple liquid chromatography method.
    Yoo JY; Kim JM; Seo KS; Jeong YK; Lee HB; Khang G
    Biomed Mater Eng; 2005; 15(4):279-88. PubMed ID: 16010036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
    Hedberg EL; Shih CK; Lemoine JJ; Timmer MD; Liebschner MA; Jansen JA; Mikos AG
    Biomaterials; 2005 Jun; 26(16):3215-25. PubMed ID: 15603816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide).
    Frank A; Kumar Rath S; Boey F; Venkatraman S
    Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH; Liang ZH; Zeng S
    Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.